These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. [Intensified insulin therapy. Is there an alternative to BE count?]. MMW Fortschr Med; 2006 Sep; 148(37):21. PubMed ID: 17036898 [No Abstract] [Full Text] [Related]
14. A randomized trial comparing continuous subcutaneous insulin infusion of insulin aspart versus insulin lispro in children and adolescents with type 1 diabetes. Weinzimer SA; Ternand C; Howard C; Chang CT; Becker DJ; Laffel LM; Diabetes Care; 2008 Feb; 31(2):210-5. PubMed ID: 17989308 [TBL] [Abstract][Full Text] [Related]
15. Effect of age of infusion site and type of rapid-acting analog on pharmacodynamic parameters of insulin boluses in youth with type 1 diabetes receiving insulin pump therapy. Swan KL; Dziura JD; Steil GM; Voskanyan GR; Sikes KA; Steffen AT; Martin ML; Tamborlane WV; Weinzimer SA Diabetes Care; 2009 Feb; 32(2):240-4. PubMed ID: 19017777 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of treatment satisfaction associated with the use of insulin aspart in continuous subcutaneous insulin infusion. Wittlin SD; Marcus AO; Weng CS; Howard CP; Schorr AB; Diabetes Technol Ther; 2008 Feb; 10(1):1-10. PubMed ID: 18275357 [TBL] [Abstract][Full Text] [Related]
17. Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review. Fordan S; Raskin P Vasc Health Risk Manag; 2009; 5(1):225-31. PubMed ID: 19436644 [TBL] [Abstract][Full Text] [Related]